These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1791718)

  • 1. [Treatment of peptic ulcer with sucralfate].
    Brailski Kh; Mendizova A; Matov V; Dimitrov B
    Klin Med (Mosk); 1991 Aug; 69(8):78-80. PubMed ID: 1791718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucralfate effervescent tablet: treatment of peptic ulcer disease and change in serum aluminium concentration.
    Schütze K; Hentschel E; Happonen P; Akkila J
    Hepatogastroenterology; 1995 Jul; 42(3):240-5. PubMed ID: 7590572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
    Classen M; Bethge H; Brunner G; Dirr B; Frotz H; Gabor M; Gail H; Grabner R; Hagenmüller F; Heinkel K
    Scand J Gastroenterol Suppl; 1983; 83():61-8. PubMed ID: 6356323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study.
    Pop P; Nikkels RE; Thys O; Dorrestein GC
    Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of duodenal ulcer healing in sucralfate treated patients.
    Haq SA; Rahman MT; Hasan M; Khan AK
    Bangladesh Med Res Counc Bull; 1996 Aug; 22(2):65-9. PubMed ID: 9103658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does co-prescription of sucralfate with ranitidine therapy enhance the healing of gastric ulcers?
    Houston LJ; Mills JG; Wood JR
    Am J Gastroenterol; 1993 May; 88(5):675-9. PubMed ID: 8480730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
    Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, double-blind trial of sucralfate and placebo in duodenal ulcer.
    McHardy GG
    J Clin Gastroenterol; 1981; 3(Suppl 2):147-52. PubMed ID: 7033351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
    Miller K
    Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled, double-blind study of sucralfate in the short-term treatment of duodenal ulcer.
    Sung JL; Yu JY; Wang TH; Wang CY; Chen DS
    Scand J Gastroenterol Suppl; 1983; 83():21-4. PubMed ID: 6356317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
    Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucralfate versus placebo treatment in duodenal and prepyloric ulcer: a clinical endoscopic, double-blind controlled investigation.
    Elsborg L; Boysen K; Bruusgaard A; Reinicke V
    Hepatogastroenterology; 1984 Dec; 31(6):269-71. PubMed ID: 6549171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sucralfate on Helicobacter pylori and severity of gastritis in patients with duodenal ulcer.
    Winter TA; Louw JA; Marks IN; Jaskiewicz K; Lucke W; Callanan M
    Scand J Gastroenterol Suppl; 1995; 210():85-8. PubMed ID: 8578216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of peptic ulcers--acid reduction or cytoprotection?
    Glise H; Carling L; Hallerbäck B; Kagevi I; Solhaug JH; Svedberg LE; Wahlby L
    Scand J Gastroenterol Suppl; 1987; 140():39-47. PubMed ID: 3328284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical sucralfate decreases pain after hemorrhoidectomy and improves healing: a randomized, blinded, controlled study.
    Gupta PJ; Heda PS; Kalaskar S; Tamaskar VP
    Dis Colon Rectum; 2008 Feb; 51(2):231-4. PubMed ID: 18095028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucralfate: worldwide experience in recurrence therapy.
    Marks IN
    J Clin Gastroenterol; 1987; 9 Suppl 1():18-22. PubMed ID: 3302008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.